Exchange: NASDAQ Sector: Financial Services Industry: Shell Companies
-0.05% $10.80
America/New_York / 6 okt 2023 @ 15:46
FUNDAMENTALS | |
---|---|
MarketCap: | 209.07 mill |
EPS: | 0.210 |
P/E: | 51.40 |
Earnings Date: | Mar 30, 2023 |
SharesOutstanding: | 19.37 mill |
Avg Daily Volume: | 0.0359 mill |
RATING 2023-10-13 |
---|
B+ |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Sell | |
Return On Asset: | Strong Buy | |
DE: | Sell | |
P/E: | Buy | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | |
Ebit | ||||||
Asset | ||||||
Debt | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 51.40 | sector: PE -18.15 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 51.40 | industry: PE -25.74 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 10.77 - 10.83 ( +/- 0.31%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-05 | Bioplus Sponsor Llc | Buy | 5 749 999 | Class A Ordinary Shares |
2023-06-05 | Bioplus Sponsor Llc | Sell | 5 749 999 | Class B Ordinary Shares |
2021-12-07 | Bioplus Sponsor Llc | Buy | 380 000 | Class A ordinary shares |
2021-12-07 | Bioplus Sponsor Llc | Buy | 0 | Sponsor Loan |
2021-12-02 | Bioplus Sponsor Llc | Buy | 5 175 000 | Class B ordinary shares |
INSIDER POWER |
---|
0.00 |
Last 83 transactions |
Buy: 9 846 749 | Sell: 7 425 476 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $10.80 (-0.05% ) |
Volume | 0.0056 mill |
Avg. Vol. | 0.0359 mill |
% of Avg. Vol | 15.68 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.